South America Endoscopic Retrograde Cholangiopancreatography Market

South America Endoscopic Retrograde Cholangiopancreatography Market Research Report By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers), By Application (Bile Duct, Pancreas, Others), By Product (Endoscopes, Imaging Devices, Energy Devices) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
9.8%
2024 Market Size
$ 228.39 Million
2035 Market Size
$ 638.83 Million
Healthcare ● Updated May 2026 Report ID: MRFR/HC/49842-HCR | Pages: 200 | Author: Rahul Gotadki
Summary Table of Contents Segmentation Download PDF
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Procedure (USD Million) | |
      1. 4.1.1 Biliary Sphincterotomy | |
      2. 4.1.2 Biliary Stenting | |
      3. 4.1.3 Biliary Dilatation | |
      4. 4.1.4 Pancreatic Duct Stenting | |
      5. 4.1.5 Others |
    2. 4.2 Healthcare, BY End User (USD Million) | |
      1. 4.2.1 Hospitals & Clinics | |
      2. 4.2.2 Ambulatory Surgical Centers |
    3. 4.3 Healthcare, BY Application (USD Million) | |
      1. 4.3.1 Bile Duct | |
      2. 4.3.2 Pancreas | |
      3. 4.3.3 Others |
    4. 4.4 Healthcare, BY Product (USD Million) | |
      1. 4.4.1 Endoscopes | |
      2. 4.4.2 Endotherapy Devices | |
      3. 4.4.3 Catheters | |
      4. 4.4.4 Stents | |
      5. 4.4.5 Balloons | |
      6. 4.4.6 Guiding Wires | |
      7. 4.4.7 Others | |
      8. 4.4.8 Imaging Devices | |
      9. 4.4.9 Energy Devices 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Boston Scientific (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Medtronic (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Olympus Corporation (JP) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Cook Medical (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Fujifilm Holdings Corporation (JP) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Conmed Corporation (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hoya Corporation (JP) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 B. Braun Melsungen AG (DE) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE |
    6. 6.3 SOUTH AMERICA MARKET ANALYSIS BY END USER |
    7. 6.4 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    8. 6.5 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
    9. 6.6 KEY BUYING CRITERIA OF HEALTHCARE |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF HEALTHCARE |
    12. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    14. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE |
    15. 6.12 HEALTHCARE, BY PROCEDURE, 2024 (% SHARE) |
    16. 6.13 HEALTHCARE, BY PROCEDURE, 2024 TO 2035 (USD Million) |
    17. 6.14 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    18. 6.15 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
    19. 6.16 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    20. 6.17 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
    21. 6.18 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
    22. 6.19 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
      4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

South America South America Endoscopic Retrograde Cholangiopancreatography Market Segmentation

South America Endoscopic Retrograde Cholangiopancreatography Market By Procedure (USD Million, 2025-2035)

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Duct Stenting
  • Others

South America Endoscopic Retrograde Cholangiopancreatography Market By End User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

South America Endoscopic Retrograde Cholangiopancreatography Market By Application (USD Million, 2025-2035)

  • Bile Duct
  • Pancreas
  • Others

South America Endoscopic Retrograde Cholangiopancreatography Market By Product (USD Million, 2025-2035)

  • Endoscopes
  • Endotherapy Devices
  • Catheters
  • Stents
  • Balloons
  • Guiding Wires
  • Others
  • Imaging Devices
  • Energy Devices
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.